Page 1
His ADHD symptoms can be disruptive, but there’s a great kid in there.
Now there’s a new way to help him out…
New for the treatment of ADHD

Spread (pages 2 and 3):
Introducing once-daily Intuniv
A new way to reach the kid within
Intuniv demonstrated significant improvement in ADHD symptoms, which can be disruptive.
New for the treatment of ADHD

To see all of the ads from this campaign, click here

Brand name: intuniv
Generic name/category: Guanfacine, Antihypertensive agents, Guanidines, Alpha-adrenergic agonists
Company: Shire
Country/Market: USA, North America
Indication(s)/use: attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: A new way to reach the kid within
Medium: Print ad
Size/duration: Three-page spread
Publication/Aired: Contemporary Pediatrics – November 2009

To see all of this brand’s ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

[Visual]
A family of four eats at a diner. While they are enjoying their meal, a robot-like creature comes out of the mouth of the youngest of the children. Mechanical sounds and a siren can be heard. Attached to the creature is a red phone which starts ringing. The parents answer it.

[Creature]
Je suis une carie. Je viens attaquer une dent de votre fille et elle va avoir mal.
I am a tooth cavity. I am here to attack the tooth of your daughter and she’ll feel pain.

[Visual]
The communication is lost and the creature gets back into the little girl’s mouth.

[Voice-over and Super]
Ne rêvez pas, les problèmes dentaires ne préviennent pas. L’assurance maladie offre aux 6-18 ans des rendez-vous de prévention chez le dentiste.
Don’t dream, dental problems do not warn you before they happen. Health insurance offers 6-18 year-old’s prevention check-ups at the dentist.

www.mtdents.info

L’Assurance maladie

Agency: BDDP Unlimited

Brand name: Assurance Maladie
Generic name/category: Health services, prevention
Country/Market: France, Europe
Indication(s)/use: Tooth decay, cavity
Target: Consumers (DTC)
Medium: TV commercial
Size/duration: 30 seconds
Publication/Aired: 2009

There are 2 sources of cholesterol. Food & Family.

Only Vytorin treats both.

Brand name: Vytorin
Generic name/category: Ezetimibe/simvastatin, Statins
Company: Merck/Schering-Plough Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: treatment of dyslipidemia
Target: Consumers (DTC)
Tagline: Treat the 2 sources of cholesterol
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Prevention – October 2009

To see all of this brand’s ads on AdPharm, click here

The longer a child with autism goes without help, the harder they are to reach.

Agency: CHI & Partners, London, UK
Creative Director: Ewan Paterson
Creative team: Alan Cinnamond and Sandy Cinnamond
Photographer: Tim McPherson
Typographer and Designer: Craig Ward

Brand name: Talk about autism
Generic name/category: public service, disease awareness
Brand name: Treehouse
Country/Market: UK, Europe
Indication(s)/use: autism
Target: Consumers (DTC)
Tagline: The longer a child with autism goes without help, the harder they are to reach.
Medium: Print ad
Size/duration: double-page spread, poster
Publication/Aired: August 2009

To see all of this brand's ads on AdPharm, click here
0 views
Sep 04, 2009

Visit AdPharm.net for more pharmaceutical ads

Perhaps you can’t see us, but we are there.

Cruz Roja.

Agency: Publicis Dialog Spain, Madrid, Spain
Chief Creative Officer: Arturo Lopez
Creative Director: David Cavanilles
Art Directors: Jaime Campiña and Juan Hernanz
Copywriter: Alfonso Cuenca

Brand name: Red Cross/Cruz Roja
Generic name/category: Humanitarian aid, corporate awareness
Company: Red Cross/Cruz Roja
Country/Market: Portugal, Europe
Indication(s)/use: public awareness
Target: Consumers (DTC)
Tagline: Perhaps you can’t see us, but we are there.
Publication: November 2008

To see all of this brand’s ads on AdPharm, click here

New Balmex with ActivGuard changes how doctors think about diaper rash

Breakthrough, dual-action formula protects like nothing else you’ve recommended.

If your patients could ask for it by name, they would! Recommend it today and end the red on their bottom

All to often, babies and children can’t-or-won’t take medication orally.
More peace of mind for parents. Fewer worried phone calls for you.

Diaper rash (U.S.) or nappy rash (UK), (also known as “Diaper dermatitis” and “Napkin dermatitis” is a generic term applied to skin rashes in the diaper area that are caused by various skin disorders and/or irritants.

Generic rash or irritant diaper dermatitis (IDD) is characterized by joined patches of erythema and scaling mainly seen on the convex surfaces, with the skin folds spared.

Diaper dermatitis with secondary bacterial or fungal involvement tends to spread to concave surfaces (i.e. skin folds), as well as convex surfaces, and often exhibits a central red, beefy erythema with satellite pustules around the border (Hockenberry, 2003).

More on Wikipedia

[Brand name: Balmex with ActivGuard
Generic name/category:zinc oxide diaper rash cream
Company: Chattem
Country/Market: USA, North America
Indication(s)/use: Diaper rash
Target: Healthcare Professionals
Tagline: Fight irritation. End the red. Recommend Balmex instead.
Publication: Contemporary Pediatrics May 2009

Today, I took steps to balance my type 2 diabetes.
Today, I chose salad and talked to my doctor.

It’s time. Crestor

Call 1-888-JANUVIA or visit Januvia.com

A different way. Januvia.

Sitagliptin (INN; previously identified as MK-0431, trade name Januvia) is an oral antihyperglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class, Sitagliptin being the only 2nd Generation DPP4 inhibitor currently available. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its lower side-effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. Exenatide (Byetta) is an alternative drug that also works with the incretin system. – Wikipedia

US News and World Report February 2009